Xeris Pharmaceuticals
XERS
#6685
Rank
$0.52 B
Marketcap
$3.49
Share price
2.35%
Change (1 day)
66.99%
Change (1 year)

Xeris Pharmaceuticals (XERS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $0.34 Billion USD

According to Xeris Pharmaceuticals's latest financial reports the company's total liabilities are $0.34 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Xeris Pharmaceuticals - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.32 B10.04%
2022-12-31$0.29 B43.13%
2021-12-31$0.20 B66.78%
2020-12-31$0.12 B32.62%
2019-12-31$94.55 M111.89%
2018-12-31$44.62 M-56.61%
2017-12-31$0.10 B57.07%
2016-12-31$65.46 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$28.07 M-91.97%๐Ÿ‡บ๐Ÿ‡ธ USA